199 related articles for article (PubMed ID: 21471213)
41. Modulation of vitamin d receptor activity by the corepressor hairless: differential effects of hairless isoforms.
Malloy PJ; Wang J; Jensen K; Feldman D
Endocrinology; 2009 Nov; 150(11):4950-7. PubMed ID: 19819974
[TBL] [Abstract][Full Text] [Related]
42. Lef1DeltaN binds beta-catenin and increases osteoblast activity and trabecular bone mass.
Hoeppner LH; Secreto FJ; Razidlo DF; Whitney TJ; Westendorf JJ
J Biol Chem; 2011 Apr; 286(13):10950-9. PubMed ID: 21270130
[TBL] [Abstract][Full Text] [Related]
43. 1alpha,25-dihydroxy vitamin D(3) induces nuclear matrix association of the 1alpha,25-dihydroxy vitamin D(3) receptor in osteoblasts independently of its ability to bind DNA.
Arriagada G; Paredes R; van Wijnen AJ; Lian JB; van Zundert B; Stein GS; Stein JL; Montecino M
J Cell Physiol; 2010 Feb; 222(2):336-46. PubMed ID: 19885846
[TBL] [Abstract][Full Text] [Related]
44. Importin 4 is responsible for ligand-independent nuclear translocation of vitamin D receptor.
Miyauchi Y; Michigami T; Sakaguchi N; Sekimoto T; Yoneda Y; Pike JW; Yamagata M; Ozono K
J Biol Chem; 2005 Dec; 280(49):40901-8. PubMed ID: 16207705
[TBL] [Abstract][Full Text] [Related]
45. Lymphoid enhancer factor-1 and beta-catenin inhibit Runx2-dependent transcriptional activation of the osteocalcin promoter.
Kahler RA; Westendorf JJ
J Biol Chem; 2003 Apr; 278(14):11937-44. PubMed ID: 12551949
[TBL] [Abstract][Full Text] [Related]
46. Control of TCF-4 expression by VDR and vitamin D in the mouse mammary gland and colorectal cancer cell lines.
Beildeck ME; Islam M; Shah S; Welsh J; Byers SW
PLoS One; 2009 Nov; 4(11):e7872. PubMed ID: 19924301
[TBL] [Abstract][Full Text] [Related]
47. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF
Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310
[TBL] [Abstract][Full Text] [Related]
48. A unique DNA binding domain converts T-cell factors into strong Wnt effectors.
Atcha FA; Syed A; Wu B; Hoverter NP; Yokoyama NN; Ting JH; Munguia JE; Mangalam HJ; Marsh JL; Waterman ML
Mol Cell Biol; 2007 Dec; 27(23):8352-63. PubMed ID: 17893322
[TBL] [Abstract][Full Text] [Related]
49. Targeting expression of the human vitamin D receptor to the keratinocytes of vitamin D receptor null mice prevents alopecia.
Chen CH; Sakai Y; Demay MB
Endocrinology; 2001 Dec; 142(12):5386-9. PubMed ID: 11713240
[TBL] [Abstract][Full Text] [Related]
50. Hairless suppresses vitamin D receptor transactivation in human keratinocytes.
Xie Z; Chang S; Oda Y; Bikle DD
Endocrinology; 2006 Jan; 147(1):314-23. PubMed ID: 16269453
[TBL] [Abstract][Full Text] [Related]
51. Vitamin D/VDR signaling suppresses microRNA-802-induced apoptosis of keratinocytes in oral lichen planus.
Zhao B; Xu N; Li R; Yu F; Zhang F; Yang F; Ge X; Li YC; Du J
FASEB J; 2019 Jan; 33(1):1042-1050. PubMed ID: 30074824
[TBL] [Abstract][Full Text] [Related]
52. Synergistic effects of coactivators GRIP1 and beta-catenin on gene activation: cross-talk between androgen receptor and Wnt signaling pathways.
Li H; Kim JH; Koh SS; Stallcup MR
J Biol Chem; 2004 Feb; 279(6):4212-20. PubMed ID: 14638683
[TBL] [Abstract][Full Text] [Related]
53. Mechanistic studies to evaluate the enhanced antiproliferation of human keratinocytes by 1alpha,25-dihydroxyvitamin D(3)-3-bromoacetate, a covalent modifier of vitamin D receptor, compared to 1alpha,25-dihydroxyvitamin D(3).
Chen ML; Ray S; Swamy N; Holick MF; Ray R
Arch Biochem Biophys; 1999 Oct; 370(1):34-44. PubMed ID: 10496974
[TBL] [Abstract][Full Text] [Related]
54. Vitamin D receptor ligands, adenomatous polyposis coli, and the vitamin D receptor FokI polymorphism collectively modulate beta-catenin activity in colon cancer cells.
Egan JB; Thompson PA; Vitanov MV; Bartik L; Jacobs ET; Haussler MR; Gerner EW; Jurutka PW
Mol Carcinog; 2010 Apr; 49(4):337-52. PubMed ID: 20043299
[TBL] [Abstract][Full Text] [Related]
55. Combined Deletion of the Vitamin D Receptor and Calcium-Sensing Receptor Delays Wound Re-epithelialization.
Oda Y; Hu L; Nguyen T; Fong C; Tu CL; Bikle DD
Endocrinology; 2017 Jun; 158(6):1929-1938. PubMed ID: 28368538
[TBL] [Abstract][Full Text] [Related]
56. Molecular modeling, affinity labeling, and site-directed mutagenesis define the key points of interaction between the ligand-binding domain of the vitamin D nuclear receptor and 1 alpha,25-dihydroxyvitamin D3.
Swamy N; Xu W; Paz N; Hsieh JC; Haussler MR; Maalouf GJ; Mohr SC; Ray R
Biochemistry; 2000 Oct; 39(40):12162-71. PubMed ID: 11015194
[TBL] [Abstract][Full Text] [Related]
57. Vitamin D3-dependent VDR signaling delays ron-mediated breast tumorigenesis through suppression of β-catenin activity.
Johnson AL; Zinser GM; Waltz SE
Oncotarget; 2015 Jun; 6(18):16304-20. PubMed ID: 26008979
[TBL] [Abstract][Full Text] [Related]
58. Nongenotropic, anti-apoptotic signaling of 1alpha,25(OH)2-vitamin D3 and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes. Mediation by Src, phosphatidylinositol 3-, and JNK kinases.
Vertino AM; Bula CM; Chen JR; Almeida M; Han L; Bellido T; Kousteni S; Norman AW; Manolagas SC
J Biol Chem; 2005 Apr; 280(14):14130-7. PubMed ID: 15671029
[TBL] [Abstract][Full Text] [Related]
59. Differences in expression and function of LEF1 isoforms in normal versus leukemic hematopoiesis.
Feder K; Edmaier-Schröger K; Rawat VPS; Kirsten N; Metzeler K; Kraus JM; Döhner K; Döhner H; Kestler HA; Feuring-Buske M; Buske C
Leukemia; 2020 Apr; 34(4):1027-1037. PubMed ID: 31758089
[TBL] [Abstract][Full Text] [Related]
60. Parathyroid hormone-related protein activates Wnt signaling to specify the embryonic mammary mesenchyme.
Hiremath M; Dann P; Fischer J; Butterworth D; Boras-Granic K; Hens J; Van Houten J; Shi W; Wysolmerski J
Development; 2012 Nov; 139(22):4239-49. PubMed ID: 23034629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
